MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.tube.2021.102127

Медицинская библиотека · Tuberculosis (Edinburgh, Scotland) · 2021

Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.

Burel Julie G, Singhania Akul, Dubelko Paige, Muller Julius, Tanner Rachel, Parizotto Eneida, Dedicoat Martin, Fletcher Thomas E, Dunbar James, Cunningham Adam F, Lindestam Arlehamn Cecilia S, Catanzaro Donald G, Catanzaro Antonino, Rodwell Timothy, McShane Helen, O'Shea Matthew K, Peters Bjoern

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Although only a small fraction will ever develop the active form of tuberculosis (ATB) disease, chemoprophylaxis treatment in latent TB infected (LTBI) individuals is an effective strategy to control pathogen transmission. Characterizing immune responses in LTBI upon chemoprophylactic treatment is important to facilitate treatment monitoring, and thus improve TB control strategies. Here, we studied changes in the blood transcriptome in a cohort of 42 LTBI and 8 ATB participants who received anti-TB therapy. Based on the expression of previously published gene signatures of progression to ATB, we stratified the LTBI cohort in two groups and examined if individuals deemed to be at elevated risk of developing ATB before treatment (LTBI-Risk) differed from others (LTBI-Other). We found that LTBI-Risk and LTBI-Other groups were associated with two distinct transcriptomic treatment signatures, with the LTBI-Risk signature resembling that of treated ATB patients. Notably, overlapping genes between LTBI-Risk and ATB treatment signatures were associated with risk of progression to ATB and interferon (IFN) signaling, and were selectively downregulated upon treatment in the LTBI-Risk but not the LTBI-Other group. Our results suggest that transcriptomic reprogramming following treatment of LTBI is heterogeneous and can be used to distinguish LTBI-Risk individuals from the LTBI cohort at large.

Для цитирования: Burel Julie G, Singhania Akul, Dubelko Paige, Muller Julius, Tanner Rachel, Parizotto Eneida, Dedicoat Martin, Fletcher Thomas E, Dunbar James, Cunningham Adam F, Lindestam Arlehamn Cecilia S, Catanzaro Donald G, Catanzaro Antonino, Rodwell Timothy, McShane Helen, O'Shea Matthew K, Peters Bjoern. Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.. Tuberculosis (Edinburgh, Scotland). 2021. DOI: 10.1016/j.tube.2021.102127.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.